IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ALOI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.812
EU - Europa 1.115
AS - Asia 1.084
SA - Sud America 154
OC - Oceania 22
AF - Africa 19
Totale 4.206
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.690
IT - Italia 540
BD - Bangladesh 288
CN - Cina 233
SG - Singapore 189
ES - Italia 109
GB - Regno Unito 89
DE - Germania 69
BR - Brasile 67
JP - Giappone 62
FR - Francia 61
HK - Hong Kong 57
CA - Canada 51
MX - Messico 48
NL - Olanda 48
TR - Turchia 47
IN - India 38
RU - Federazione Russa 38
VN - Vietnam 38
AR - Argentina 33
PL - Polonia 32
IL - Israele 27
AU - Australia 22
KR - Corea 22
FI - Finlandia 20
GR - Grecia 18
CL - Cile 16
CO - Colombia 16
TW - Taiwan 15
AT - Austria 13
CH - Svizzera 13
ID - Indonesia 13
PE - Perù 11
SA - Arabia Saudita 11
SE - Svezia 11
BE - Belgio 9
KZ - Kazakistan 8
HU - Ungheria 7
PK - Pakistan 7
GT - Guatemala 6
HR - Croazia 6
IE - Irlanda 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
JM - Giamaica 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
RS - Serbia 4
TH - Thailandia 4
ZA - Sudafrica 4
CI - Costa d'Avorio 3
EC - Ecuador 3
HN - Honduras 3
IQ - Iraq 3
JO - Giordania 3
LV - Lettonia 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
UY - Uruguay 3
BB - Barbados 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
UA - Ucraina 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
DK - Danimarca 1
IR - Iran 1
ML - Mali 1
NI - Nicaragua 1
NP - Nepal 1
QA - Qatar 1
SV - El Salvador 1
Totale 4.206
Salva come PNG Salva come JPEG
Città #
Dallas 594
Santa Clara 240
Council Bluffs 139
Ashburn 116
Singapore 99
Milan 93
San Jose 70
New York 62
Rome 61
Southend 50
Los Angeles 45
Hefei 44
Hong Kong 37
Beijing 32
Bologna 29
Madrid 28
Naples 23
Tel Aviv 22
Buenos Aires 19
Buffalo 19
Helsinki 18
Istanbul 18
Amsterdam 17
Boardman 17
Chicago 17
Paris 16
Shanghai 16
São Paulo 16
Turin 15
Ankara 14
Ho Chi Minh City 14
Pittsburgh 14
Tokyo 14
Frankfurt am Main 13
Hanoi 13
Miano 13
Atlanta 12
Bari 12
Bengaluru 12
Miami 12
Moscow 12
Warsaw 12
Lauterbourg 11
Sydney 11
Toronto 11
Vienna 10
Guangzhou 9
Lima 9
Astana 8
Charlotte 8
Gdansk 8
Hull 8
San Nicolás de los Garza 8
Santiago 8
Verona 8
Athens 7
Brescia 7
Cleveland 7
Genoa 7
Hangzhou 7
Pasadena 7
Tinley Park 7
Valencia 7
Zurich 7
Barcelona 6
Dearborn 6
Dublin 6
Hanover 6
Matadepera 6
Melbourne 6
Milpitas 6
Monterrey 6
Mutsukawa 6
Nanjing 6
Osaka 6
Padua 6
Porto Alegre 6
Riyadh 6
Seoul 6
Shepherdsville 6
Stuttgart 6
Tainan City 6
Taipei 6
Zagreb 6
Bellwood 5
Benito Juarez 5
Budapest 5
Catania 5
Chennai 5
Columbus 5
Denver 5
Florence 5
Guatemala City 5
Messina 5
Montreal 5
Munich 5
Philadelphia 5
Portland 5
Prague 5
Rouen 5
Totale 2.519
Salva come PNG Salva come JPEG
Nome #
Management of paediatric ulcerative colitis, part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition 1.008
Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization 462
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation 438
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 320
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 145
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey 127
Pan-enteric Capsule Endoscopy to Characterize Crohn's Disease Phenotypes and Predict Clinical Outcomes in Children and Adults: The Bomiro Study 118
Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD 114
Quality of life reported by Italian children with IBD and their parents: Preliminary results of a multicenter SIGENP study 110
Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach 98
Argon plasma coagulator in a 2-month-old child with tracheoesophageal fistula 84
Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in Children: A Multicenter Prospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition 76
Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation 74
Prevalence and trend of anemia in children with inflammatory bowel disease: A national register-based cohort study 54
The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn’s Disease 51
Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study 47
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN 42
Impact of 5‐ASA discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study 42
Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group 36
Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features 33
Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review 30
Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group 30
Real-life durability and risk factors for biologic discontinuation in pediatric inflammatory bowel disease: results from the SIGENP IBD registry 30
The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome 27
Exploring novel biomarkers in pediatric ulcerative colitis: The role of Lipocalin-2, MMP-9, and MMP-9/LCN-2 complex 26
Pediatric autoimmune gastritis: An international, multicentric study 25
Diagnostic Delay of Celiac Disease in Childhood 25
A European survey on digestive perianastomotic ulcerations, a rare Crohn-like disorder occurring in children and young adults 23
Diagnosis and management of anemia in pediatric inflammatory bowel diseases: Clinical practice guidelines on behalf of the SIGENP IBD Working group 22
Long‐term outcome of pediatric acute severe colitis: A prospective 5‐year follow‐up of the PRASCO trial 21
Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial 20
Update on pediatric inflammatory bowel diseases epidemiology during SARS-CoV-2 outbreak:data from the Italian society of pediatric gastroenterology, epatology and nutrition registry 18
The medical management of paediatric Crohn's disease: an ECCO-ESPGHAN guideline update 17
International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study 17
Clinical Features and Outcomes of Paediatric Patients With Isolated Colonic Crohn Disease 16
European Crohn's and Colitis Organisation consensus on dietary management of inflammatory bowel disease 16
A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn’s Disease Improves Outcomes at 2 Years 16
De Novo Crohn’s Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch–Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN 15
Prevalence and outcomes of arthritis in pediatric IBD: A multicenter study from the Italian Society of Pediatric Gastroenterology Hepatology and Nutrition 14
Predicting outcomes in pediatric Crohn's disease for management optimization: systematic review and consensus statements from the pediatric inflammatory bowel disease–ahead program 14
Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: a multicenter study 14
Management of pediatric inflammatory bowel diseases in limited-resource settings: A position paper from the Paediatric IBD Porto Group of ESPGHAN 14
Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment 13
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study 13
Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study 13
Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease 13
Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper 13
Dietary habits in Italian children with inflammatory bowel disease: A case‐control multicenter study 13
Real-life use of biosimilars in pediatric inflammatory bowel disease: a nation-wide web survey on behalf of the SIGENP IBD working group 12
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease 12
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 12
Histologic findings at diagnosis as predictive markers of clinical outcome in pediatric ulcerative colitis 11
The importance of gut microbiome in the perinatal period 11
Investigation of small bowel in pediatric Crohn's disease 11
Diagnostic accuracy of multimodal noninvasive follow-up for pediatric ulcerative colitis: A single-center prospective study 11
Prevalence and clinical features of chronic uveitis in pediatric inflammatory bowel diseases: A nationwide study 11
Intestinal inflammation alters the expression of hepatic bile acid receptors causing liver impairment 11
Capsule endoscopy followed by single balloon enteroscopy in children with obscure gastrointestinal bleeding. A combined approach 10
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study 10
Predicting outcomes in pediatric ulcerative colitis for management optimization: systematic review and consensus statements from the pediatric inflammatory bowel disease–ahead program 10
Is fecal calprotectin a useful marker for small bowel Crohn's disease? 10
Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn's disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient 10
Is transmural healing better than mucosal healing in pediatric Crohn’s disease? 9
Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in pediatric Inflammatory Bowel Disease: clinical characteristics and outcomes 9
A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release 9
Treatment options and outcomes of pediatric IBDU compared with other IBD subtypes: A retrospective multicenter study from the IBD porto group of ESPGHAN 9
Multidisciplinary Perinatal Care in IBD 9
Endoplasmic reticulum stress and unfolded protein response are involved in paediatric inflammatory bowel disease 9
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease 9
Can liver biopsy be spared for the diagnosis of autoimmune hepatitis in selected children? A multicenter retrospective study 9
Drug Development: The Use of Unlicensed/Off-label Medicines in Pediatrics 8
Disease course and efficacy of medical therapy in stricturing paediatric Crohn's disease 8
Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: A randomized, double-blind, placebo controlled trial 8
Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre 8
Management of paediatric ulcerative colitis, part 2: Acute severe colitis - An evidence-based consensus guideline from the european Crohn's and colitis organization and the european society of paediatric gastroenterology, hepatology and nutrition 8
Necroptosis Is Active in Children With Inflammatory Bowel Disease and Contributes to Heighten Intestinal Inflammation 8
In children eradication of Helicobacter pylori does not promote gastro-oesophageal reflux disease: A multichannel pH-impedance study 8
Biological therapy In a Pediatric Crohn's disease population followed at a referral center 8
Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial 8
Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: efficacy of infliximab as a rescue therapy 8
Atopic manifestations in children born preterm: a long-term observational study 8
Response to Letter to the Editor: “Prevalence and trend of anemia in children with inflammatory bowel disease” 8
Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response 8
A prospective 52-week mucosal healing and deep remission assessment of small bowel and colonic Crohn’s disease as detected by colon capsule endoscopy 8
Autoimmune Enteropathy in a 13-Year-Old Celiac Girl Successfully Treated With Infliximab 8
Disease activity patterns in the first 5 years after diagnosis in children with ulcerative colitis: a population-based study 8
Efficacy of gelatin tannate for acute diarrhea in children: A systematic review and meta-analysis 8
Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice 8
Identifying health economic considerations to include in the research protocol of a randomized controlled trial (the REDUCE-RISK Trial): Systematic literature review and assessment 8
Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN 8
Long-term effects on growth of an energy-enhanced parenteral nutrition in preterm newborn: a quasi-experimental study 8
Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say? 8
Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course 8
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mix 8
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease 8
A prospective 24-week mucosal healing and deep-remission assessment of small bowel and colonic Crohn's disease as detected by colon capsule endoscopy 7
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN 7
Inflammatory bowel disease-unclassified in children: diagnosis and pharmacological management 7
Looking beyond mucosal healing: effect of biologic therapy on transmural healing in pediatric Crohn's disease 7
Mucosal healing in Crohn's disease: new insights 7
Totale 4.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/202219 1 0 1 3 1 2 2 2 1 3 0 3
2022/20237 2 0 2 0 1 2 0 0 0 0 0 0
2023/202413 0 0 1 0 2 0 0 0 1 4 3 2
2024/2025336 1 10 0 7 14 10 6 10 14 22 105 137
2025/20264.252 161 165 800 197 203 106 152 120 246 436 747 919
Totale 4.698